Fig. 4From: Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysisForest plot of the HR for DFS of HER2-low breast cancer vs. HER2-zero breast cancer in overall cohort (a), HR-positive group(b), HR-negative group(c)Back to article page